查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1979981

生物科學電子市場預測至2034年：按產品類型、設備、應用、最終用戶和地區分類的全球分析

Biosciences Electronics Market Forecasts to 2034 - Global Analysis By Product Type (Wearable Biosensors, Implantable Biosensors and Non-invasive Biosensors), Device, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的研究，預計到 2026 年，全球生物科學電子市場將達到 107.2 億美元，在預測期內以 11.3% 的複合年成長率成長，到 2034 年將達到 252.3 億美元。

生物電子學（生物科學電子學）是將生物學和電子學相結合，設計用於醫療、診斷和環境應用的高級裝置的領域。它專注於開發感測器、穿戴式裝置和植入，以實現生物訊號追蹤、生理狀態測量和精準醫療。生物組件與電子系統的整合能夠實現即時監測、個人化醫療和改善臨床療效。這項技術在現代診斷、藥物研發和生物技術領域中發揮著至關重要的作用，推動著精準醫療和智慧醫療創新，同時實現了生物平台和電子平台之間的無縫互動。

根據美國國立衛生研究院 (NIH) 的說法，生物電子醫學被認為是一個很有前景的領域，它利用各種設備來調節神經迴路並治療慢性疾病。 NIH 正在資助該領域的幾項研究，包括迷走神經刺激 (VNS) 用於治療自體免疫疾病和發炎性疾病。然而，NIH 並未正式定義類風濕性關節炎症狀「減輕 30-50%」的具體意義。該數據並非 NIH 公佈的統計數據。

對個人化醫療的需求日益成長

生物科學電子市場正受到個人化醫療日益成長的關注的顯著影響。穿戴式和植入式生物電子設備能夠持續監測個別健康指標，並支持客製化治療策略。透過根據患者獨特的生物學特徵量身定做治療方法，這些解決方案能夠最大限度地減少副作用並改善治療效果。臨床醫生和患者對個人化醫療的認知不斷提高，推動了先進生物電子技術在診斷、慢性病管理和即時監測領域的應用。因此，隨著醫療保健從標準化方法轉向利用生物電子技術的患者個別化干涉，該市場正經歷顯著成長。

生物電子設備高成本

生物電子設備的高成本對市場構成重大挑戰。開發先進的穿戴式和植入式設備需要昂貴的材料、精密組件和複雜的製造程序，因此難以以可承受的價格提供。高昂的價格限制了發展中地區和低收入患者群體獲得這些設備的機會，阻礙了其廣泛應用。醫療機構也可能因為缺乏成本效益證明而猶豫不決。此外，操作和維護方面的專業培訓進一步增加了整體成本。因此，高昂的製造成本、部署成本和營運成本阻礙了生物電子解決方案的大規模應用，並減緩了全球市場的成長。

遠端醫療和數位醫療保健的擴展

遠端醫療和數位醫療的擴展為生物電子市場帶來了巨大的成長潛力。穿戴式和遠端監測生物電子設備能夠向遠端醫療系統提供即時患者訊息，從而實現遠距離診斷和持續監測。這種整合有助於實現個人化護理，並減少患者就醫次數。全球範圍內數位醫療解決方案的日益普及預計將推動對生物電子設備的需求。此外，新興市場遠端醫療的發展創造了新的機遇，並鼓勵對經濟高效、擴充性且互聯互通的生物電子技術進行投資，以滿足全球不同患者群體的需求。

市場參與者之間競爭激烈

市場參與企業之間的激烈競爭是生物電子產業面臨的主要威脅。無論是老牌製造商或新興Start-Ups，都在競相推出先進的穿戴式裝置、植入式裝置和診斷設備。價格競爭、技術的快速變革以及強力的行銷策略迫使企業在控制成本的同時快速創新。小規模的公司難以滿足這些需求，這可能導致市場整合。日益激烈的競爭正在擠壓利潤空間並阻礙產品普及，使得新參與企業和現有企業都難以在快速發展的生物電子領域中維持成長並保持競爭力。

新冠疫情的影響：

新冠疫情對生物電子市場造成了嚴重衝擊，加速了穿戴式裝置、遠端監測系統和遠端醫療平台的快速普及。保持社交距離的措施和醫療資源的緊張凸顯了對慢性疾病患者和出現新冠症狀者進行即時、非侵入性監測的必要性。各國政府和私營機構大力投資生物電子研發和數位醫療基礎設施，以加強抗疫能力。儘管供應鏈挑戰和生產延誤暫時影響了市場，但疫情凸顯了生物電子技術在遠距離診斷、個人化醫療和數位醫療解決方案中的重要性，從而推動了市場的長期成長。

在預測期內，穿戴式生物感測器領域預計將佔據最大的市場佔有率。

由於其便利性、非侵入性和持續監測健康指標的能力，穿戴式生物感測器領域預計將在預測期內佔據最大的市場佔有率。健身追蹤器、智慧型手錶和感測器貼片等設備能夠即時追蹤生命徵象和其他生理數據，從而支援遠端醫療並減少就醫需求。人們對個人化醫療、慢性病管理和遠端監測日益成長的興趣正在推動對穿戴式裝置的需求。與人工智慧、行動應用程式和雲端系統的兼容性有助於提高患者參與度並實現數據驅動的醫療保健解決方案，使穿戴式生物感測器成為全球生物電子市場的主導細分領域。

在預測期內，居家醫療領域預計將呈現最高的複合年成長率。

在預測期內，受遠端監測、個人化治療和居家慢性病管理需求不斷成長的推動，居家醫療領域預計將呈現最高的成長率。包括穿戴式和非侵入式感測器在內的生物電子設備，使患者無需頻繁就醫即永續監測生命徵象和其他健康指標，從而降低醫療成本。與遠距遠端醫療服務、行動應用程式和雲端分析的整合，提高了患者參與度和護理效率。日益增強的健康意識、生物電子技術的進步以及老年人口的成長，正在推動居家醫療解決方案的快速普及，使其成為所有細分市場中成長率最高的領域。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其完善的醫療保健基礎設施和數位健康解決方案的廣泛應用。強大的研發投入、領先的生物電子公司以及有利的監管政策正在推動穿戴式、植入式和非侵入式設備的開發和商業化。對個人化醫療、遠端監測和慢性病管理日益成長的需求也促進了市場成長。生物電子技術與人工智慧、物聯網和遠端醫療平台的融合將提升醫療服務和病人參與。這些因素共同確保北美繼續保持全球生物電子市場最大區域貢獻者的地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療基礎設施的不斷改進、醫療支出的增加以及人們對創新醫療技術的日益關注。穿戴式裝置、植入和非侵入式生物電子設備在遠端監測和慢性病管理方面的應用正在加速。政府的支持政策、技術的進步以及遠端醫療服務的擴展進一步刺激了市場需求。大規模的老齡人口和慢性病盛行率的上升創造了巨大的市場機會，使亞太地區成為全球生物電子產業成長最快的地區。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 主要國家的市場估算和預測，以及根據客戶需求量身定做的複合年成長率（註：需要進行可行性測試）。
  • 競爭性標竿分析
    • 根據主要參與者的產品系列、地理覆蓋範圍和策略聯盟進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球生物科學電子產品市場：依產品類型分類

  • 穿戴式生物感測器
  • 植入式生物感測器
  • 非侵入式生物感測器

第6章 全球生物科學電子市場：依設備分類

  • 生物電子設備
  • 生物電子醫學
  • 生物電子技術

第7章 全球生物科學電子市場：依應用分類

  • 衛生保健
  • 環境監測
  • 食品安全
  • 工業應用

第8章：全球生物科學電子產品市場：依最終用戶分類

  • 醫院
  • 居家醫療
  • 研究所
  • 工業設施

第9章 全球生物科學電子市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories
  • GE Healthcare
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Salvia BioElectronics
  • Synchron
  • Cochlear Ltd
  • LivaNova PLC
  • BIOTRONIK
  • Nevro Corp
  • Nova Biomedical
  • Dexcom, Inc.
  • Analog Devices, Inc.
Product Code: SMRC34144

According to Stratistics MRC, the Global Biosciences Electronics Market is accounted for $10.72 billion in 2026 and is expected to reach $25.23 billion by 2034 growing at a CAGR of 11.3% during the forecast period. Bioelectronics, or biosciences electronics, merges biology with electronic engineering to design advanced devices for healthcare, diagnostics, and environmental applications. It emphasizes the development of sensors, wearables, and implants that track biological signals, measure physiological conditions, and administer precise treatments. Integrating biological components with electronic systems allows real-time monitoring, personalized therapies, and enhanced clinical outcomes. This technology plays a vital role in modern diagnostics, pharmaceutical research, and biotechnology, promoting precision medicine and intelligent healthcare innovations while creating seamless interactions between living organisms and electronic platforms.

According to the National Institutes of Health (NIH), bioelectronic medicine is recognized as a promising field that uses devices to modulate neural circuits for treating chronic diseases. NIH has funded multiple studies in this area, including vagus nerve stimulation (VNS) for autoimmune and inflammatory conditions. However, NIH does not officially state a fixed "30-50% reduction" figure in rheumatoid arthritis symptoms. That number is not an NIH-published statistic.

Market Dynamics:

Driver:

Rising demand for personalized healthcare

The biosciences electronics market is strongly influenced by the rising focus on personalized healthcare. Wearable and implantable bioelectronic devices enable continuous monitoring of individual health metrics, supporting customized treatment strategies. By adjusting therapies according to a patient's unique biological profile, these solutions minimize side effects and improve outcomes. Growing awareness of personalized care among clinicians and patients is driving the adoption of advanced bioelectronics in diagnostics, chronic illness management, and real-time monitoring. Consequently, the market experiences significant growth as healthcare transitions from standard approaches to patient-specific interventions that leverage bioelectronic technology.

Restraint:

High cost of bioelectronic devices

The expensive nature of bioelectronic devices poses a major challenge to the market. Developing advanced wearable and implantable devices involves costly materials, precision components, and intricate manufacturing, making them less affordable. High prices restrict access in developing regions and among patients with limited income, curbing adoption. Healthcare providers may also be reluctant to invest without demonstrable cost-effectiveness. Additionally, specialized training for operation and maintenance adds to the overall expense. As a result, the high production, implementation, and operational costs hinder the large-scale deployment of bioelectronics solutions and slow overall market growth worldwide.

Opportunity:

Expansion of telemedicine and digital health

The expansion of telemedicine and digital healthcare offers substantial growth potential for the biosciences electronics market. Wearable and remote monitoring bioelectronic devices can feed real-time patient information into telehealth systems, facilitating remote diagnostics and continuous monitoring. This integration allows for personalized care and reduces the need for hospital visits. Increasing adoption of digital health solutions globally is expected to drive demand for bioelectronics devices. Additionally, the growth of telemedicine in emerging markets creates new opportunities, promoting investment in cost-effective, scalable, and connected bioelectronic technologies that cater to diverse patient populations worldwide.

Threat:

Intense competition among market players

High competition among market participants is a major threat to the biosciences electronics industry. Both established manufacturers and emerging startups are vying to launch advanced wearable, implantable, and diagnostic devices. Competitive pricing, fast technological changes, and strong marketing tactics force companies to innovate rapidly while managing costs. Smaller firms may find it difficult to meet these demands, potentially leading to consolidation in the market. Increased rivalry can compress profit margins and hinder adoption rates, making it challenging for new entrants and existing players to sustain growth and remain competitive in the rapidly evolving bioelectronics sector.

Covid-19 Impact:

The COVID-19 outbreak had a profound impact on the biosciences electronics market, driving rapid adoption of wearable devices, remote monitoring systems, and telemedicine platforms. Social distancing measures and stressed healthcare facilities increased the need for real-time, non-invasive monitoring of patients with chronic conditions and COVID-19 symptoms. Governments and private organizations invested heavily in bioelectronics R&D and digital health infrastructure to improve pandemic response. Although supply chain challenges and production delays temporarily affected the market, the pandemic ultimately highlighted the importance of bioelectronics in remote diagnostics, personalized healthcare, and digital health solutions, fostering long-term market growth.

The wearable biosensors segment is expected to be the largest during the forecast period

The wearable biosensors segment is expected to account for the largest market share during the forecast period due to their convenience, non-invasive nature, and ability to offer continuous monitoring of health metrics. Devices like fitness trackers, smartwatches, and sensor patches enable real-time tracking of vital signs and other physiological data, supporting remote healthcare and reducing the need for hospital visits. Rising emphasis on personalized medicine, chronic disease management, and remote monitoring has boosted demand for wearable devices. Their compatibility with AI, mobile apps, and cloud systems enhances patient engagement and enables data-driven healthcare solutions, making wearable biosensors the leading segment in the global bioelectronics market.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate due to increasing demand for remote monitoring, personalized treatment, and chronic disease management at home. Bioelectronic devices, including wearable and non-invasive sensors, allow patients to continuously track vital signs and other health metrics without frequent hospital visits, lowering healthcare expenses. Their connection with telehealth services, mobile applications, and cloud analytics improves patient participation and care effectiveness. Rising health awareness, advancements in bioelectronics technology, and a growing elderly population are driving the accelerated adoption of home healthcare solutions, resulting in the highest growth rate among all market segments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, attributed to its well-established healthcare infrastructure and widespread adoption of digital health solutions. Strong R&D investment, presence of leading bioelectronics companies, and supportive regulatory policies encourage the development and commercialization of wearable, implantable, and non-invasive devices. Rising demand for personalized healthcare, remote monitoring, and management of chronic diseases also contributes to market growth. Integration of bioelectronics with AI, IoT, and telemedicine platforms enhances healthcare delivery and patient engagement. These factors collectively ensure that North America remains the largest regional contributor to the global bioelectronics market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by enhancements in healthcare infrastructure, increased spending, and greater awareness of innovative medical technologies. The adoption of wearable, implantable, and non-invasive bioelectronic devices for remote monitoring and chronic condition management is accelerating. Supportive government policies, advances in technology, and the expansion of telehealth services further stimulate demand. A large, aging population and increasing chronic disease prevalence create substantial market opportunities, positioning Asia-Pacific as the fastest-growing region in the global biosciences electronics industry.

Key players in the market

Some of the key players in Biosciences Electronics Market include Medtronic, Abbott Laboratories, Boston Scientific, Siemens Healthineers, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Salvia BioElectronics, Synchron, Cochlear Ltd, LivaNova PLC, BIOTRONIK, Nevro Corp, Nova Biomedical, Dexcom, Inc. and Analog Devices, Inc.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In January 2026, Boston Scientific Corporation and Penumbra, Inc. announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Product Types Covered:

  • Wearable Biosensors
  • Implantable Biosensors
  • Non-invasive Biosensors

Devices Covered:

  • Bio-electronic Devices
  • Bio-electronic Medicine
  • Bio-electronic Technology

Applications Covered:

  • Healthcare
  • Environmental Monitoring
  • Food Safety
  • Industrial Applications

End Users Covered:

  • Hospitals
  • Home Healthcare
  • Research Laboratories
  • Industrial Facilities

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biosciences Electronics Market, By Product Type

  • 5.1 Wearable Biosensors
  • 5.2 Implantable Biosensors
  • 5.3 Non-invasive Biosensors

6 Global Biosciences Electronics Market, By Device

  • 6.1 Bio-electronic Devices
  • 6.2 Bio-electronic Medicine
  • 6.3 Bio-electronic Technology

7 Global Biosciences Electronics Market, By Application

  • 7.1 Healthcare
  • 7.2 Environmental Monitoring
  • 7.3 Food Safety
  • 7.4 Industrial Applications

8 Global Biosciences Electronics Market, By End User

  • 8.1 Hospitals
  • 8.2 Home Healthcare
  • 8.3 Research Laboratories
  • 8.4 Industrial Facilities

9 Global Biosciences Electronics Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Medtronic
  • 12.2 Abbott Laboratories
  • 12.3 Boston Scientific
  • 12.4 Siemens Healthineers
  • 12.5 F. Hoffmann-La Roche Ltd
  • 12.6 Bio-Rad Laboratories
  • 12.7 GE Healthcare
  • 12.8 Thermo Fisher Scientific
  • 12.9 Danaher Corporation
  • 12.10 Salvia BioElectronics
  • 12.11 Synchron
  • 12.12 Cochlear Ltd
  • 12.13 LivaNova PLC
  • 12.14 BIOTRONIK
  • 12.15 Nevro Corp
  • 12.16 Nova Biomedical
  • 12.17 Dexcom, Inc.
  • 12.18 Analog Devices, Inc.

List of Tables

  • Table 1 Global Biosciences Electronics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biosciences Electronics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Biosciences Electronics Market Outlook, By Wearable Biosensors (2023-2034) ($MN)
  • Table 4 Global Biosciences Electronics Market Outlook, By Implantable Biosensors (2023-2034) ($MN)
  • Table 5 Global Biosciences Electronics Market Outlook, By Non-invasive Biosensors (2023-2034) ($MN)
  • Table 6 Global Biosciences Electronics Market Outlook, By Device (2023-2034) ($MN)
  • Table 7 Global Biosciences Electronics Market Outlook, By Bio-electronic Devices (2023-2034) ($MN)
  • Table 8 Global Biosciences Electronics Market Outlook, By Bio-electronic Medicine (2023-2034) ($MN)
  • Table 9 Global Biosciences Electronics Market Outlook, By Bio-electronic Technology (2023-2034) ($MN)
  • Table 10 Global Biosciences Electronics Market Outlook, By Application (2023-2034) ($MN)
  • Table 11 Global Biosciences Electronics Market Outlook, By Healthcare (2023-2034) ($MN)
  • Table 12 Global Biosciences Electronics Market Outlook, By Environmental Monitoring (2023-2034) ($MN)
  • Table 13 Global Biosciences Electronics Market Outlook, By Food Safety (2023-2034) ($MN)
  • Table 14 Global Biosciences Electronics Market Outlook, By Industrial Applications (2023-2034) ($MN)
  • Table 15 Global Biosciences Electronics Market Outlook, By End User (2023-2034) ($MN)
  • Table 16 Global Biosciences Electronics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 17 Global Biosciences Electronics Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 18 Global Biosciences Electronics Market Outlook, By Research Laboratories (2023-2034) ($MN)
  • Table 19 Global Biosciences Electronics Market Outlook, By Industrial Facilities (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.